Figures index

From

Laser Ablation Synthesized Copper Nanoparticles for Cancer Treatment: An Animal Cell Line Studies

Mahadevaiah, Nawneet K. Kurrey, Gowtham G. K, Thejas Urs G, Somashekar R

American Journal of Cancer Prevention. 2018, 6(2), 35-40 doi:10.12691/ajcp-6-2-5
  • Figure 1. Ablation setup (a) and the solutions containing copper nano particles (b)
  • Figure 2. Elemental analysis which shows the percentage of Cu. (a) 30min b) 60 mins c) 90mins (d) 120 and (e) 150 mins of time durations (f) Pure Copper Target
  • Figure 3. Particle size distribution obtained for the solutions (a) 30 (b) 60 (c) 90 (d) 120 (e) 150 mins of time durations
  • Figure 4. UV –Visible Results show different Ablation Duration, 1)30 mins 2) 60 mins 3) 90 mins 4)120 mins
  • Figure 5. MTT assay for cytotoxicity (%) of CuNPs in noncancerous NIH3T3 cells
  • Figure 6. MTT assay for cytotoxicity (%) of CuNPs in human breast cancer MDA-MB-231 cells: Bar graph showing the cell viability (%) of cells treated with different CuNPs of varying concentration
  • Figure 7. Comparison of cytotoxicity (%) of the murine melanoma B16F10 cells exposed to CuNPs done by MTT assay. Bar graph showing the cell viability (%) of cells treated with different CuNPs of varying concentration
  • Figure 8. MTT assay for cytotoxicity (%) of CuNPs in human colon cancer HCT-15 cells: Bar graph showing the cell viability (%) of cells treated with different CuNPs of varying concentration
  • Figure 9. Hindu devotees taking holy bath at river Ganges
  • Figure 10. Representative phase contrast images of control and NPs treated cells. (Top) Comparison of cytotoxicity (%) of the murine melanoma B16F10 cells exposed to NPs done by MTT assay (Bottom) MTT assay for cytotoxicity (%) of NPs in human colon cancer HT-29 cells